Identification of ovarian cancer symptoms in health insurance claims data

Journal of Women's Health

Volumn 19, Issue 3, 2010, Pages 381-389

  Devlin, Sean M ^a   Diehr, Paula H ^a   Andersen, M Robyn ^a,b   Goff, Barbara A ^c   Tyree, Patrick T ^a   Lafferty, William E ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FALSE POSITIVE RESULT; FEMALE; HEALTH INSURANCE; HUMAN; INCIDENT REPORT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; OVARY CANCER; PELVIS PAIN SYNDROME; PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ABDOMINAL PAIN; ADULT; COST-BENEFIT ANALYSIS; FALSE POSITIVE REACTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INSURANCE CLAIM REVIEW; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC PAIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINATION DISORDERS;

EID: 77950264825     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1550     Document Type: Article

References (24)

1. American Cancer Society. Estimated new cancer cases and deaths by sex, U.S., 2008. Available at www.cancer.org/ docroot/MED/content/downloads/MED-1-1x- CFF2008- Estimated-Cancer-Cases-Deaths-All.asp Accessed December 9, 2008.
2. SEER Cancer Statistics Review 1975-2005. Available at seer.cancer.gov/statistics/ Accessed December 19, 2008.
3. Goff BA, Mandel L, Muntx HG, Melancon CH. Ovarian carcinoma diagnosis: Results of a national ovarian cancer survey. Cancer 2000;89:2068-2075.
4. Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol 2001;83:466-471.
5. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obste Gynecol 2001;98:1150-1151.
6. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004;291:2705-2712.
7. Wynn ML, Chang S, Peipins LA. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. Womens Health 2007;16:971-982.
8. Smith lH, Morries CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS. Ovarian cancer: Can we make the clinical diagnosis earlier? Cancer 2005;104:1398-1407.
9. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: Possibilities for earlier detection. Cancer 2007;109:221-227.
10. Andersen MR, Goff BA, Lowe KA, et al. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer 2008;113:484-489.
11. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the U.K. Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol Published online March 11, 2009.
12. Partridge E, Kreimer AR, Greenlee RT, et al. Results from four rounds of ovarian cancer screening in a randomized trail. Gynecol Oncol 2009;113:775-782.
13. Havrilesky LJ, Sanders GD, Kulasingam S, Myers ER. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it? Gynecol Oncol 2008;doi:10.1016/j.ygno .2008.07.006.
14. Washington State Statute Law Committee. Health plan requirements. Revised code of Washington. Olympia, WA: Statue Law Committee. 2000;48:43.045.
15. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: A national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-1121.
16. Lafferty WE, Tyree PT, Bellas AS, et al. Insurance coverage and subsequent utilization of complementary and alternative medicine providers. Am J Manag Care 2006;12:397-404.
17. Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care 2008;14:326-334.
18. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343-2350.
19. American Medical Association. International classification of diseases, 9th revision, Clinical modification: Physician. Chicago: AMA Press, 2003.
20. Gold MR, Siegel JE, Russell LB, Weinstein MC. Costeffectiveness in health and medicine. New York: Oxford University Press, 1996.
21. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2006. Available at www.R-project.org
22. Clarke-Pearson DL. Clinical Practice: Screening for ovarian cancer. N Engl J Med 2009;361:170-177.
23. Pokras R, Hufnagel VG, National Center for Health Statistics. Hysterectomies in the United States, 1965-1984. Vital and health statistics. Series 13, No. 92 Washington DC: Government Printing Office, 1987.
24. Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance-United States, 1994-1999. Centers for Disease Control: Surveillance summaries. 2002;51:55-65